About Advanced Clinical Research
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
2
Galderma R&D
2
Hoffmann-La Roche
1
Pfizer
1
Clinical Trials at Advanced Clinical Research
During the past decade, Advanced Clinical Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on
average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX
2013-11-07
2016-10-14
Completed
718
An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate
2014-08-01
2016-12-01
Completed
1,152
A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol
2014-10-01
2015-12-01
Terminated
366
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
2015-11-30
2018-08-09
Completed
862
Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines
2020-01-27
2021-05-21
Completed
902
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Advanced Clinical Research
According to Clinical.Site data, the most researched conditions in "Advanced Clinical Research" are
"Glabellar Lines" (1 trials), "Hyperlipidemia" (1 trials), "Lateral Canthal Lines" (1 trials), "Lip Augmentation" (1 trials) and "Migraine" (1 trials). Many other conditions were trialed in "Advanced Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Advanced Clinical Research
Most popular intervention types in "Advanced Clinical Research" are "Drug" (4 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Adalimumab with methotrexate" (1 trials), "Atorvastatin" (1 trials), "Device: FDA Approved Dermal Filler" (1 trials) and "Evacetrapib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Advanced Clinical Research
The vast majority of trials in "Advanced Clinical Research" are
6 trials for "All" genders.
Clinical Trials Status at Advanced Clinical Research
Currently, there are NaN active trials in "Advanced Clinical Research".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Advanced Clinical Research,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Advanced Clinical Research, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".